Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search


74 results
4:07 PM, Jun 05, 2018  |  BC Extra | Company News

Management tracks: Sarepta, Gilead

said CFO Gary Titus is stepping down. COO Stephen Mullennix will serve as interim CFO. GPCR
2:30 PM, Jan 19, 2018  |  BC Extra | Company News

Management tracks: Shire, Sosei

plc (LSE: SHP, NASDAQ: SHPG) on March 19. The company announced his hiring in November. GPCR
10:03 PM, Dec 18, 2017  |  BC Extra | Company News

Confo, Roche in GPCR deal

granted Roche (SIX:ROG; OTCQX:RHHBY) exclusive, worldwide rights to its small molecule agonists against an undisclosed GPCR
declined to disclose details. Confo's Confobodies mimic the role of the G protein to stabilize GPCRs …
began a separate discovery collaboration with H. Lundbeck A/S (CSE:LUN) centered on two other undisclosed GPCRs …
11:42 AM, May 03, 2017  |  BC Extra | Company News

Sosei invests in MiNA, gets option to acquire

said the deal is consistent with its strategy to identify technologies that could complement its GPCR-targeted …
5:30 PM, Jan 13, 2016  |  BC Extra | Company News

Boehringer, Arena strike CNS deal

granted Boehringer Ingelheim GmbH (Ingelheim, Germany) exclusive, worldwide rights to drug candidates targeting an undisclosed GPCR
7:11 PM, Nov 30, 2015  |  BC Extra | Company News

Pfizer, Heptares strike GPCR deal

that would give the pharma exclusive, worldwide rights to therapeutics targeting up to 10 undisclosed GPCRs …
6:05 PM, Feb 21, 2013  |  BC Extra | Company News

UCB, ConfometRx in GPCR discovery deal

UCB Group (Euronext:UCB) and structural biology company ConfometRx (Santa Clara, Calif.) partnered to research GPCR modulation …
disclose details. ConfometRx is developing structure-based drug discovery technologies for lead identification and optimization for GPCRs …
The technologies include technologies that characterize ligand-induced structural changes and generate GPCR-specific, functional antibodies for target …
6:10 PM, Jan 07, 2013  |  BC Extra | Company News

Heptares, Cubist in GPCR discovery deal

U.K.) and Cubist Pharmaceuticals Inc. (NASDAQ:CBST) partnered to discover and develop compounds against two undisclosed GPCR
6:20 PM, Oct 23, 2012  |  BC Extra | Company News

Domain, Ono in GPCR deal

will use its DTect-All drug discovery platform to design and optimize small molecules targeting undisclosed GPCRs …
research funding and is eligible for milestones, plus royalties. Domain said Ono has selected one GPCR
6:27 PM, Jul 23, 2012  |  BC Extra | Company News

Boehringer to acquire Funxional's somatotaxin portfolio

remaining portfolio includes its GAEL technology to generate libraries of novel small molecules enriched in GPCR